FACULTY OF PHARMACEUTICAL MEDICINE

1
REVALIDATION
INTRODUCTION UPDATE
Dr Susan Bews President and Chair of the
Revalidation Steering Committee Faculty of
Pharmaceutical Medicine
FACULTY OF PHARMACEUTICAL MEDICINE
2
TOPICS

• Faculty Update
• Components of revalidation
• Revalidation for Pharmaceutical
• Physicians in
• a) managed environments and,
• b) non-managed environments

FACULTY OF PHARMACEUTICAL MEDICINE
3
FACULTY UPDATE

• Meetings with the Department of Health
• Work of the Revalidation Steering
• Committee
• Work with the Academy of Medical Royal
• Colleges (AoMRC)
• Response to DH consultation on
• Responsible Officer regulations

FACULTY OF PHARMACEUTICAL MEDICINE
4
COMPONENTS OF REVALIDATION 1
Revalidation
One process, two outcomes
Recertification (holders of CCT or CESR)
Relicensing
FACULTY OF PHARMACEUTICAL MEDICINE
5
COMPONENTS OF REVALIDATION 2
1. Five-year cycle. 2. Facultys Specialty
Specific Standards for revalidation
(applicable for all PPs). 3. Annual appraisal
- Review of supporting information (e.g. CPD,
MSF) 4. Responsible Officer - Quality assures
revalidation system within organisation
doctor works - Recommends to GMC doctor fit
to practise
FACULTY OF PHARMACEUTICAL MEDICINE
6
ROLE OF THE FACULTY

• Will provide appraisals, MSF and RO
• These processes could be used in full/part by
  all PPs whether employed or independent
• However managed environments likely to have
  their own ROs to whom PPs would link
• The same specialty specific standards will apply
  to all

FACULTY OF PHARMACEUTICAL MEDICINE